首页 > 最新文献

Medical alphabet最新文献

英文 中文
Telogen effluvium (literature review) 脱发(文献综述)
Pub Date : 2024-07-20 DOI: 10.33667/2078-5631-2024-9-16-18
A. R. Ereshko, N. Gryazeva, S. R. Mayransaeva
The article is devoted to current issues of etiopathogenesis, diagnosis and treatment of telogen effluvium. Literature data on rational injection and hardware methods of therapy, including modern fractional laser therapy, are provided. A number of mechanisms of the therapeutic effect of physical factors have been revealed.
文章主要讨论了毛囊性脱发的发病机制、诊断和治疗等当前问题。文章提供了有关合理注射和硬件治疗方法(包括现代点阵激光疗法)的文献资料。文章揭示了物理因素治疗效果的若干机制。
{"title":"Telogen effluvium (literature review)","authors":"A. R. Ereshko, N. Gryazeva, S. R. Mayransaeva","doi":"10.33667/2078-5631-2024-9-16-18","DOIUrl":"https://doi.org/10.33667/2078-5631-2024-9-16-18","url":null,"abstract":"The article is devoted to current issues of etiopathogenesis, diagnosis and treatment of telogen effluvium. Literature data on rational injection and hardware methods of therapy, including modern fractional laser therapy, are provided. A number of mechanisms of the therapeutic effect of physical factors have been revealed.","PeriodicalId":18337,"journal":{"name":"Medical alphabet","volume":"61 8","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141819210","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effect of exposure factors on acne 暴露因素对痤疮的影响
Pub Date : 2024-07-20 DOI: 10.33667/2078-5631-2024-9-31-37
N. Gryazeva, A. V. Bezborodova, V. E. Kazaryan, M. S. Kruglova
The skin, being a border organ that provides a protective function and is constantly exposed to the environment. In the scientific literature, the generally accepted term “exposome factors” is used to describe exogenous factors. By influencing the skin barrier and skin microbiota, they have a significant impact on the course of acne, which is confirmed by numerous studies. The term “exposure” is understood as the total measure of exposure to the environment and associated biological reactions on a person throughout life. Identification of the most common factors that increase the risk of developing acne and reducing their impact on the skin is an integral part in solving the problem of acne treatment. The article presents data from a literature review and our own research on the influence of exposure factors on the course of acne.
皮肤是一个具有保护功能的边界器官,经常暴露在环境中。在科学文献中,"暴露体因素 "这个公认的术语被用来描述外源性因素。它们通过影响皮肤屏障和皮肤微生物群,对痤疮的病程产生重大影响,这一点已被大量研究证实。所谓 "暴露",是指一个人一生中暴露于环境和相关生物反应的总和。找出增加痤疮发病风险的最常见因素并减少其对皮肤的影响,是解决痤疮治疗问题不可或缺的一部分。本文介绍了有关暴露因素对痤疮病程影响的文献综述和我们自己的研究数据。
{"title":"The effect of exposure factors on acne","authors":"N. Gryazeva, A. V. Bezborodova, V. E. Kazaryan, M. S. Kruglova","doi":"10.33667/2078-5631-2024-9-31-37","DOIUrl":"https://doi.org/10.33667/2078-5631-2024-9-31-37","url":null,"abstract":"The skin, being a border organ that provides a protective function and is constantly exposed to the environment. In the scientific literature, the generally accepted term “exposome factors” is used to describe exogenous factors. By influencing the skin barrier and skin microbiota, they have a significant impact on the course of acne, which is confirmed by numerous studies. The term “exposure” is understood as the total measure of exposure to the environment and associated biological reactions on a person throughout life. Identification of the most common factors that increase the risk of developing acne and reducing their impact on the skin is an integral part in solving the problem of acne treatment. The article presents data from a literature review and our own research on the influence of exposure factors on the course of acne.","PeriodicalId":18337,"journal":{"name":"Medical alphabet","volume":"111 9","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141820430","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Drug-induced agranulocytosis – prevalence, complications, management tactics 药物诱发粒细胞减少症--发病率、并发症、管理策略
Pub Date : 2024-05-14 DOI: 10.33667/2078-5631-2024-13-57-61
A. A. Pecherskikh, B. A. Chaparyan, N. Orlova, T. V. Pinchuk, E. S. Chernenok, N. D. Karseladze
Based on the results of a review of clinical cases and research data, the prevalence of drug-induced agranulocytosis, complications and management tactics are considered. A clinical case of agranulocytosis caused by taking nonsteroidal anti-inflammatory drugs (NSAIDs) is presented. The patient was admitted to the purulent surgical department with purulent lymphadenitis and sepsis. During the examination, agranulocytosis was revealed against the background of constant intake of NSAIDs (Aertal, Diclofenac, ibuprofen) for 3 years for joint pain. Surgical treatment was performed and antibiotic therapy was prescribed. Against the background of Filgrastim therapy, a positive dynamics of peripheral blood parameters was noted. The use of granulocyte colony stimulating factors (G-CSF) significantly reduces the severity of the disease, reduces the duration of hospitalization and mortality in patients with drug-associated agranulocytosis.
根据对临床病例和研究数据的回顾结果,探讨了药物诱发粒细胞减少症的发病率、并发症和处理策略。本文介绍了一例因服用非甾体抗炎药(NSAIDs)而导致粒细胞减少的临床病例。患者因化脓性淋巴结炎和败血症入住化脓性外科。检查发现,粒细胞减少症的背景是患者因关节疼痛持续服用非甾体抗炎药(爱尔他、双氯芬酸、布洛芬)3 年。患者接受了手术治疗和抗生素治疗。在 Filgrastim 治疗的背景下,外周血参数出现了积极的动态变化。使用粒细胞集落刺激因子(G-CSF)可明显减轻药物相关粒细胞减少症患者的病情严重程度,缩短住院时间,降低死亡率。
{"title":"Drug-induced agranulocytosis – prevalence, complications, management tactics","authors":"A. A. Pecherskikh, B. A. Chaparyan, N. Orlova, T. V. Pinchuk, E. S. Chernenok, N. D. Karseladze","doi":"10.33667/2078-5631-2024-13-57-61","DOIUrl":"https://doi.org/10.33667/2078-5631-2024-13-57-61","url":null,"abstract":"Based on the results of a review of clinical cases and research data, the prevalence of drug-induced agranulocytosis, complications and management tactics are considered. A clinical case of agranulocytosis caused by taking nonsteroidal anti-inflammatory drugs (NSAIDs) is presented. The patient was admitted to the purulent surgical department with purulent lymphadenitis and sepsis. During the examination, agranulocytosis was revealed against the background of constant intake of NSAIDs (Aertal, Diclofenac, ibuprofen) for 3 years for joint pain. Surgical treatment was performed and antibiotic therapy was prescribed. Against the background of Filgrastim therapy, a positive dynamics of peripheral blood parameters was noted. The use of granulocyte colony stimulating factors (G-CSF) significantly reduces the severity of the disease, reduces the duration of hospitalization and mortality in patients with drug-associated agranulocytosis.","PeriodicalId":18337,"journal":{"name":"Medical alphabet","volume":"102 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140978056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stress-induced arterial hypertension in the ESH Guidelines for the Management of Hypertension 2023 ESH 2023 年高血压管理指南中的应激性动脉高血压
Pub Date : 2024-05-14 DOI: 10.33667/2078-5631-2024-13-52-56
K. V. Glibko, A. Y. Starokozheva, N. A. Plotnikova, N. V. Shchepetin, N. Orlova, E. S. Nikаnorova, T. I. Hasanov
New ESH data on risk factors for arterial hypertension are presented. The article examines the mechanisms of the relationship between stress and arterial hypertension, the relationship of stress with white coat hypertension and masked arterial hypertension, perioperative hypertension. A brief review of the results of clinical studies on the relationship between chronic stress and arterial hypertension, including stress at work and in everyday life, is presented. Modern approaches to the prevention and treatment of stress-induced hypertension are considered, which include recommendations for lifestyle changes, stress management methods, and drug therapy.
文章介绍了ESH关于动脉高血压危险因素的新数据。文章探讨了压力与动脉高血压之间的关系机制、压力与白大衣高血压和掩饰性动脉高血压、围手术期高血压之间的关系。文章简要回顾了有关慢性压力与动脉高血压之间关系的临床研究结果,包括工作和日常生活中的压力。考虑了预防和治疗压力引起的高血压的现代方法,包括改变生活方式、压力管理方法和药物治疗的建议。
{"title":"Stress-induced arterial hypertension in the ESH Guidelines for the Management of Hypertension 2023","authors":"K. V. Glibko, A. Y. Starokozheva, N. A. Plotnikova, N. V. Shchepetin, N. Orlova, E. S. Nikаnorova, T. I. Hasanov","doi":"10.33667/2078-5631-2024-13-52-56","DOIUrl":"https://doi.org/10.33667/2078-5631-2024-13-52-56","url":null,"abstract":"New ESH data on risk factors for arterial hypertension are presented. The article examines the mechanisms of the relationship between stress and arterial hypertension, the relationship of stress with white coat hypertension and masked arterial hypertension, perioperative hypertension. A brief review of the results of clinical studies on the relationship between chronic stress and arterial hypertension, including stress at work and in everyday life, is presented. Modern approaches to the prevention and treatment of stress-induced hypertension are considered, which include recommendations for lifestyle changes, stress management methods, and drug therapy.","PeriodicalId":18337,"journal":{"name":"Medical alphabet","volume":"2 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140979610","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Features of acute coronary syndrome in migrant workers 外来务工人员急性冠脉综合征的特征
Pub Date : 2024-05-14 DOI: 10.33667/2078-5631-2024-13-47-51
N. V. Shchepetin, G. A. Chuvarayan, N. Orlova, Y. Fedulaev, S. Arakelov, I. Y. Titova, Yu. Yu. Yakushev
Cardiovascular diseases of migrant workers are an additional burden on the health care system of many countries in Europe, the United States, and Russia. The prevalence of risk factors among migrants is associated with the country of origin of migrants, the duration of migration, low socioeconomic conditions of residence in the host country, psychological stress, significant physical exertion, violations of work and rest, malnutrition, the spread of harmful factors (smoking, alcohol, narcotic substances), limited access to medical services. The results of the study are presented, indicating that smoking is more common among migrant workers, hypertension levels, total cholesterol, triglycerides, high-density lipoproteins, and low-density lipoproteins are higher in comparison with the indigenous inhabitants of Russia. When performing coronary angiography in patients with acute coronary syndrome in migrant workers, despite their younger age, several vascular lesions are significantly more often detected. The data of the conducted study demonstrate high risks of cardiovascular diseases among migrant workers, which requires organizational measures to prevent them.
移徙工人的心血管疾病是欧洲、美国和俄罗斯许多国家医疗保健系统的额外负担。风险因素在移民中的流行与移民的原籍国、移民时间长短、在东道国居住的社会经济条件低下、心理压力、大量体力劳动、违反作息时间、营养不良、有害因素(吸烟、酗酒、麻醉品)的传播、获得医疗服务的机会有限等因素有关。研究结果表明,与俄罗斯本地居民相比,外来务工人员中吸烟者更多,高血压水平、总胆固醇、甘油三酯、高密度脂蛋白和低密度脂蛋白更高。在对外来务工人员急性冠状动脉综合征患者进行冠状动脉造影检查时,尽管他们的年龄较小,但却更容易发现一些血管病变。研究数据表明,外来务工人员罹患心血管疾病的风险很高,需要采取组织措施加以预防。
{"title":"Features of acute coronary syndrome in migrant workers","authors":"N. V. Shchepetin, G. A. Chuvarayan, N. Orlova, Y. Fedulaev, S. Arakelov, I. Y. Titova, Yu. Yu. Yakushev","doi":"10.33667/2078-5631-2024-13-47-51","DOIUrl":"https://doi.org/10.33667/2078-5631-2024-13-47-51","url":null,"abstract":"Cardiovascular diseases of migrant workers are an additional burden on the health care system of many countries in Europe, the United States, and Russia. The prevalence of risk factors among migrants is associated with the country of origin of migrants, the duration of migration, low socioeconomic conditions of residence in the host country, psychological stress, significant physical exertion, violations of work and rest, malnutrition, the spread of harmful factors (smoking, alcohol, narcotic substances), limited access to medical services. The results of the study are presented, indicating that smoking is more common among migrant workers, hypertension levels, total cholesterol, triglycerides, high-density lipoproteins, and low-density lipoproteins are higher in comparison with the indigenous inhabitants of Russia. When performing coronary angiography in patients with acute coronary syndrome in migrant workers, despite their younger age, several vascular lesions are significantly more often detected. The data of the conducted study demonstrate high risks of cardiovascular diseases among migrant workers, which requires organizational measures to prevent them.","PeriodicalId":18337,"journal":{"name":"Medical alphabet","volume":"18 8","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140981500","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The level of highly sensitive C-reactive protein and mortality within a year after discharge from the hospital in patients with chronic heart failure with preserved ejection fraction 高敏 C 反应蛋白水平与射血分数保留的慢性心力衰竭患者出院后一年内的死亡率
Pub Date : 2024-05-14 DOI: 10.33667/2078-5631-2024-13-61-67
Yu. S. Belozerskikh, A. I. Kochetkov, V. B. Dashabylova, G. V. Lepekhin, A. A. Puhaeva, O. D. Ostroumova
Background. In recent years, there has been a steady trend in the form of an increase in the number of polymorbid patients with chronic heart failure with preserved ejection fraction (CHFpEF) and an increase in the frequency of its decompensation, which leads to an increased risk of adverse outcomes and increased mortality rates.Objective: to study the mortality structure in patients with CHFpEF within 1 year from the moment of discharge after initial hospitalization for decompensation of heart failure, as well as the level of highly sensitive C-reactive protein (hs-CRP) and clinical and laboratory characteristics of patients depending on the outcome.Methods. The data of patients with CHFpEF were retrospectively analyzed within 1 year from the moment of discharge after hospitalization due to decompensation of heart failure (n=372; median age 72.6 [63.3; 82.8] years, women – 44.4 %, NYHA class III and IV chronic heart failure, respectively, had 79.3 % and 15.9 % of patients). The concentration of hs-CRP in serum was determined in all patients during the first 24 hours after admission to the hospital.Results. During the follow-up, 65 deaths were registered (17.5 % of the included patients), of which 56 (86.2 % of all deaths) were caused by cardiovascular and cerebrovascular events – acute myocardial infarction (30 cases, 46.2 %), postinfarction cardiosclerosis (11 cases, 16.9 %), ischemic stroke (10 cases, 15.4 %), and rupture of an aortic aneurysm (1 case, 1.5 %). The level of hs-CRP compared with the surviving patients (4.84 [3.78; 5.88] mg/l) was statistically significantly higher both in the group of deaths from cardiovascular causes (5.22 [4.53; 6.21] mg/l, p=0.029) and in the group of deaths from all causes (5.33[4.49; 6.19] mg/l, p=0.020). A comparative analysis of patient characteristics revealed that patients who died from cardiovascular causes, compared with survivors, had a statistically significantly lower body mass index (p=0.046), higher total cholesterol (p=0.002), and aspartate aminotransferase (p=0.025). When comparing patients who died from all causes with patients without a fatal outcome, statistically significant differences in similar indicators were obtained.Conclusion. In patients with CHFpEF, both cardiovascular mortality and all-cause mortality within 1 year after hospitalization for decompensation of heart failure may be associated with sluggish inflammation, as well as an initially lower body mass index, higher total cholesterol and indirect signs of more pronounced myocardial damage.
背景。近年来,射血分数保留的慢性心力衰竭(CHFpEF)多病态患者人数呈稳步上升趋势,其失代偿的频率也在增加,这导致不良后果的风险增加,死亡率上升。目的:研究CHFpEF患者在因心衰失代偿而首次住院后出院后1年内的死亡率结构,以及高敏C反应蛋白(hs-CRP)水平和患者的临床及实验室特征对结果的影响。我们对因心衰失代偿而住院的 CHFpEF 患者出院后一年内的数据进行了回顾性分析(372 人,中位年龄 72.6 [63.3; 82.8] 岁,女性占 44.4%,NYHA III 级和 IV 级慢性心衰患者分别占 79.3% 和 15.9%)。所有患者都在入院后的 24 小时内测定了血清中的 hs-CRP 浓度。在随访期间,共有65人死亡(占随访患者的17.5%),其中56人(占死亡总数的86.2%)死于心脑血管事件--急性心肌梗死(30例,占46.2%)、梗死后心脏硬化(11例,占16.9%)、缺血性中风(10例,占15.4%)和主动脉瘤破裂(1例,占1.5%)。与存活患者相比,心血管原因死亡组(5.22 [4.53; 6.21] mg/l,p=0.029)和所有原因死亡组(5.33[4.49; 6.19] mg/l,p=0.020)的 hs-CRP 水平(4.84 [3.78; 5.88] mg/l)均显著高于存活患者。对患者特征的比较分析表明,与存活者相比,死于心血管疾病的患者的体重指数(p=0.046)、总胆固醇(p=0.002)和天冬氨酸氨基转移酶(p=0.025)均显著低于存活者。如果将死于各种原因的患者与无死亡结果的患者进行比较,在类似指标上存在显著的统计学差异。CHFpEF患者因心衰失代偿住院后1年内的心血管死亡和全因死亡可能与炎症反应迟缓、最初体重指数较低、总胆固醇较高和心肌损伤较明显的间接迹象有关。
{"title":"The level of highly sensitive C-reactive protein and mortality within a year after discharge from the hospital in patients with chronic heart failure with preserved ejection fraction","authors":"Yu. S. Belozerskikh, A. I. Kochetkov, V. B. Dashabylova, G. V. Lepekhin, A. A. Puhaeva, O. D. Ostroumova","doi":"10.33667/2078-5631-2024-13-61-67","DOIUrl":"https://doi.org/10.33667/2078-5631-2024-13-61-67","url":null,"abstract":"Background. In recent years, there has been a steady trend in the form of an increase in the number of polymorbid patients with chronic heart failure with preserved ejection fraction (CHFpEF) and an increase in the frequency of its decompensation, which leads to an increased risk of adverse outcomes and increased mortality rates.Objective: to study the mortality structure in patients with CHFpEF within 1 year from the moment of discharge after initial hospitalization for decompensation of heart failure, as well as the level of highly sensitive C-reactive protein (hs-CRP) and clinical and laboratory characteristics of patients depending on the outcome.Methods. The data of patients with CHFpEF were retrospectively analyzed within 1 year from the moment of discharge after hospitalization due to decompensation of heart failure (n=372; median age 72.6 [63.3; 82.8] years, women – 44.4 %, NYHA class III and IV chronic heart failure, respectively, had 79.3 % and 15.9 % of patients). The concentration of hs-CRP in serum was determined in all patients during the first 24 hours after admission to the hospital.Results. During the follow-up, 65 deaths were registered (17.5 % of the included patients), of which 56 (86.2 % of all deaths) were caused by cardiovascular and cerebrovascular events – acute myocardial infarction (30 cases, 46.2 %), postinfarction cardiosclerosis (11 cases, 16.9 %), ischemic stroke (10 cases, 15.4 %), and rupture of an aortic aneurysm (1 case, 1.5 %). The level of hs-CRP compared with the surviving patients (4.84 [3.78; 5.88] mg/l) was statistically significantly higher both in the group of deaths from cardiovascular causes (5.22 [4.53; 6.21] mg/l, p=0.029) and in the group of deaths from all causes (5.33[4.49; 6.19] mg/l, p=0.020). A comparative analysis of patient characteristics revealed that patients who died from cardiovascular causes, compared with survivors, had a statistically significantly lower body mass index (p=0.046), higher total cholesterol (p=0.002), and aspartate aminotransferase (p=0.025). When comparing patients who died from all causes with patients without a fatal outcome, statistically significant differences in similar indicators were obtained.Conclusion. In patients with CHFpEF, both cardiovascular mortality and all-cause mortality within 1 year after hospitalization for decompensation of heart failure may be associated with sluggish inflammation, as well as an initially lower body mass index, higher total cholesterol and indirect signs of more pronounced myocardial damage.","PeriodicalId":18337,"journal":{"name":"Medical alphabet","volume":"111 13","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140977773","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anticholinergic burden and the cognitive functions in elderly and senile patients with arterial hypertension 抗胆碱能药物负担与老年动脉高血压患者的认知功能
Pub Date : 2024-05-14 DOI: 10.33667/2078-5631-2024-13-68-73
O. D. Ostroumova, K. K. Dzamikhov, A. I. Kochetkov, Т. M. Ostroumova, E. Y. Ebzeyeva, А. I. Andrianov, V. B. Dashabylova
The aim of the study was to evaluate the effect of anticholinergic load (AHN) on cognitive functions (CF) in elderly and senile multimorbid patients with arterial hypertension (AH).Materials and methods. 330 patients aged 60 years and older with essential AH were included in the study (median age 79 [72; 84] years, 158 (51 %) of women). All the patients were underwent the assesment of CF using the Montreal Cognitive Assessment Scale (MoCA), Mini-Mental Status Scale (MMS), Alzheimer’s Disease Assessment Scale-Cognitive (ADAS-cog), Trial Making Test (TMT), Digit Symbol Substitution Test (DSST), Verbal Association Test (literal (letter) and categorical (animal) associations), Boston Naming Test (BNT), Word-Color Interference Test, Stroop colorword conflict test. The anticholinergic load was determined using the anticholinergic load scale (Anticholinergic Cognitive Burden Scale, ACB).Results. Compared with patients who do not take anticholinergic drugs, multimorbid elderly and senile hypertensive patients with 2 or more points on the ACB scale had significantly lower final scores on the MoCA test (23 [21; 24.3] versus 24 [22; 25] points, respectively, p=0.042) and on MMSE (26 [24; 29] vs. 27.5 [25; 29] points, respectively, p=0.015), they spent statistically more time completing part B of the TMT test (217.5 [187.3; 246.3] vs. 204 [166.8; 247.3] seconds, respectively, p=0.038). The difference between the execution time of part B and part A of the TMT test in patients with 2 or more points on the ACB scale was statistically significantly greater than in patients with 0 points on this scale (141 [103.8; 168.5] versus 124 [83.8; 162] sec, respectively, p=0.034). Age, gender, education, and the structure of concomitant diseases did not differ between the groups.Conclusion. The results obtained indicate the adverse effect of аnticholinergic вurden on CF of multimorbid elderly and senile hypertensive patients and dictate the need to optimize pharmacotherapy in this category of patients.
该研究旨在评估抗胆碱能负荷(AHN)对老年多病动脉高血压(AH)患者认知功能(CF)的影响。研究共纳入 330 名 60 岁及以上的基本动脉高血压患者(中位年龄 79 [72; 84] 岁,女性 158 人(51%))。所有患者均使用蒙特利尔认知评估量表 (MoCA)、迷你精神状态量表 (MMS)、阿尔茨海默病认知评估量表 (ADAS-cog)、试做测试 (TMT)、数字符号替换测试 (DSST)、言语联想测试(字面联想(字母)和分类联想(动物))、波士顿命名测试 (BNT)、词-色干扰测试、Stroop 色词冲突测试进行了 CF 评估。使用抗胆碱能负荷量表(抗胆碱能认知负荷量表,ACB)确定抗胆碱能负荷。与未服用抗胆碱能药物的患者相比,ACB量表上有2个或更多点的多病老年和老年高血压患者在MoCA测试(分别为23 [21; 24.3] 点和24 [22; 25] 点,P=0.042)和 MMSE(分别为 26 [24; 29] 分 vs. 27.5 [25; 29] 分,p=0.015),他们完成 TMT 测试 B 部分所花费的时间在统计学上更长(分别为 217.5 [187.3; 246.3] 秒 vs. 204 [166.8; 247.3] 秒,p=0.038)。在统计学上,ACB 量表上有 2 点或更多点的患者执行 TMT 测试 B 部分和 A 部分所需的时间差异明显大于该量表上只有 0 点的患者(分别为 141 [103.8; 168.5] 秒对 124 [83.8; 162] 秒,P=0.034)。两组患者的年龄、性别、教育程度和伴随疾病的结构没有差异。研究结果表明,抗胆碱能药物对多病老年高血压患者的CF有不利影响,因此需要优化这类患者的药物治疗。
{"title":"Anticholinergic burden and the cognitive functions in elderly and senile patients with arterial hypertension","authors":"O. D. Ostroumova, K. K. Dzamikhov, A. I. Kochetkov, Т. M. Ostroumova, E. Y. Ebzeyeva, А. I. Andrianov, V. B. Dashabylova","doi":"10.33667/2078-5631-2024-13-68-73","DOIUrl":"https://doi.org/10.33667/2078-5631-2024-13-68-73","url":null,"abstract":"The aim of the study was to evaluate the effect of anticholinergic load (AHN) on cognitive functions (CF) in elderly and senile multimorbid patients with arterial hypertension (AH).Materials and methods. 330 patients aged 60 years and older with essential AH were included in the study (median age 79 [72; 84] years, 158 (51 %) of women). All the patients were underwent the assesment of CF using the Montreal Cognitive Assessment Scale (MoCA), Mini-Mental Status Scale (MMS), Alzheimer’s Disease Assessment Scale-Cognitive (ADAS-cog), Trial Making Test (TMT), Digit Symbol Substitution Test (DSST), Verbal Association Test (literal (letter) and categorical (animal) associations), Boston Naming Test (BNT), Word-Color Interference Test, Stroop colorword conflict test. The anticholinergic load was determined using the anticholinergic load scale (Anticholinergic Cognitive Burden Scale, ACB).Results. Compared with patients who do not take anticholinergic drugs, multimorbid elderly and senile hypertensive patients with 2 or more points on the ACB scale had significantly lower final scores on the MoCA test (23 [21; 24.3] versus 24 [22; 25] points, respectively, p=0.042) and on MMSE (26 [24; 29] vs. 27.5 [25; 29] points, respectively, p=0.015), they spent statistically more time completing part B of the TMT test (217.5 [187.3; 246.3] vs. 204 [166.8; 247.3] seconds, respectively, p=0.038). The difference between the execution time of part B and part A of the TMT test in patients with 2 or more points on the ACB scale was statistically significantly greater than in patients with 0 points on this scale (141 [103.8; 168.5] versus 124 [83.8; 162] sec, respectively, p=0.034). Age, gender, education, and the structure of concomitant diseases did not differ between the groups.Conclusion. The results obtained indicate the adverse effect of аnticholinergic вurden on CF of multimorbid elderly and senile hypertensive patients and dictate the need to optimize pharmacotherapy in this category of patients.","PeriodicalId":18337,"journal":{"name":"Medical alphabet","volume":"6 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140981963","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness and safety of PCSK9 inhibitors in children with family hypercholesterolemia PCSK9 抑制剂对家族性高胆固醇血症儿童的有效性和安全性
Pub Date : 2024-05-14 DOI: 10.33667/2078-5631-2024-13-74-80
R. A. Khachaturyan, L. Khidirova, A. E. Karavozova
Familial hypercholesterolemia (CGHS) is a monogenic disease with a predominantly autosomal dominant type of inheritance, accompanied by a significant increase in the level of low-density lipoprotein cholesterol in the blood, and as a result, premature development and progressive course of atherosclerosis, usually at a young age. One of the common causes of the disease is a mutation in the PCSK9 gene. Proprotein convertase subtilisin/kexin type 9 (PCSK9) is the main link in the regulation of blood lipid metabolism due to its direct participation in the degradation of LDL receptors. Currently, only evolocumab is used as PCSK9 inhibitors in children over 12 years of age in the Russian Federation, which has proven the safety and steady reduction of LDL cholesterol in pediatric patients with HES. Another representative of this pharmacological group is alirocumab, which is currently indicated only for people over the age of 18, due to the lack of evidence in children.
家族性高胆固醇血症(CGHS)是一种主要为常染色体显性遗传的单基因疾病,伴有血液中低密度脂蛋白胆固醇水平的显著升高,并因此导致动脉粥样硬化的过早发展和进行性病程,通常在年轻时发病。该病的常见病因之一是 PCSK9 基因突变。Proprotein convertase subtilisin/kexin type 9(PCSK9)直接参与降解低密度脂蛋白受体,是调节血脂代谢的主要环节。目前,在俄罗斯联邦,只有 evolocumab 作为 PCSK9 抑制剂用于 12 岁以上的儿童,其安全性和稳定降低 HES 儿童患者的低密度脂蛋白胆固醇已得到证实。该药剂组的另一个代表药物是 alirocumab,由于缺乏儿童用药证据,目前只适用于 18 岁以上人群。
{"title":"Effectiveness and safety of PCSK9 inhibitors in children with family hypercholesterolemia","authors":"R. A. Khachaturyan, L. Khidirova, A. E. Karavozova","doi":"10.33667/2078-5631-2024-13-74-80","DOIUrl":"https://doi.org/10.33667/2078-5631-2024-13-74-80","url":null,"abstract":"Familial hypercholesterolemia (CGHS) is a monogenic disease with a predominantly autosomal dominant type of inheritance, accompanied by a significant increase in the level of low-density lipoprotein cholesterol in the blood, and as a result, premature development and progressive course of atherosclerosis, usually at a young age. One of the common causes of the disease is a mutation in the PCSK9 gene. Proprotein convertase subtilisin/kexin type 9 (PCSK9) is the main link in the regulation of blood lipid metabolism due to its direct participation in the degradation of LDL receptors. Currently, only evolocumab is used as PCSK9 inhibitors in children over 12 years of age in the Russian Federation, which has proven the safety and steady reduction of LDL cholesterol in pediatric patients with HES. Another representative of this pharmacological group is alirocumab, which is currently indicated only for people over the age of 18, due to the lack of evidence in children.","PeriodicalId":18337,"journal":{"name":"Medical alphabet","volume":"27 7","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140980470","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spectral analysis of heart rate variability in patients with newly diagnosed atrial fibrillation 新诊断心房颤动患者的心率变异性频谱分析
Pub Date : 2024-05-13 DOI: 10.33667/2078-5631-2024-13-42-46
O. T. Bogova, A. V. Sviridenko, V. N. Potapov
Spectral analysis of heart rate variability gives an idea of the role of the autonomic nervous system in the regulation of chronotropic heart function and can be used to evaluate the effectiveness of drug therapy. The selection of drug therapy taking into account the individual clinical form of atrial fibrillation, as well as the vegetative status of the patient, will undoubtedly increase the effectiveness of treatment. In this study, spectral parameters were studied in patients with newly diagnosed atrial fibrillation and the effect of the antiarrhythmic drug class III miodarone on these parameters.
通过对心率变异性的频谱分析,可以了解自律神经系统在调节时相心脏功能中的作用,并可用于评估药物治疗的效果。考虑到心房颤动的个体临床形式以及患者的植物神经状态来选择药物治疗,无疑会提高治疗效果。本研究对新诊断出的心房颤动患者的频谱参数以及抗心律失常药物 III 类药物米碘酮对这些参数的影响进行了研究。
{"title":"Spectral analysis of heart rate variability in patients with newly diagnosed atrial fibrillation","authors":"O. T. Bogova, A. V. Sviridenko, V. N. Potapov","doi":"10.33667/2078-5631-2024-13-42-46","DOIUrl":"https://doi.org/10.33667/2078-5631-2024-13-42-46","url":null,"abstract":"Spectral analysis of heart rate variability gives an idea of the role of the autonomic nervous system in the regulation of chronotropic heart function and can be used to evaluate the effectiveness of drug therapy. The selection of drug therapy taking into account the individual clinical form of atrial fibrillation, as well as the vegetative status of the patient, will undoubtedly increase the effectiveness of treatment. In this study, spectral parameters were studied in patients with newly diagnosed atrial fibrillation and the effect of the antiarrhythmic drug class III miodarone on these parameters.","PeriodicalId":18337,"journal":{"name":"Medical alphabet","volume":"100 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140984192","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term effects of radiation therapy in outpatient practice 门诊放疗的长期影响
Pub Date : 2024-05-13 DOI: 10.33667/2078-5631-2024-13-34-41
N. D. Karseladze, O. A. Tiganova, L. Ilyenko, N. Orlova, S. Z. Danelyan
Moscow multidisciplinary clinical center «Kommunarka», Moscow, Russia SUMMARY Radiation therapy is one of the main methods of treating malignant neoplasms. Along with high efficiency, radiation therapy leads to complications in the early and late period. General practitioners and therapists are insufficiently familiar with long-term radiation-induced complications. The article presents data on the pathogenesis, clinical manifestations, diagnosis and treatment of radiation lesions of the bone system, lungs, myocardium, gastrointestinal tract, genitourinary system, hematopoiesis system, as well as chronic pain syndrome. The symptoms of late complications of radiation therapy are nonspecific and similar to the symptoms of somatic diseases. Knowledge of the clinical manifestations of radiation-induced complications in the long term allows timely diagnosis and treatment.
莫斯科多学科临床中心 "Kommunarka",俄罗斯莫斯科 摘要 放射治疗是治疗恶性肿瘤的主要方法之一。在高效治疗的同时,放射治疗也会导致早期和晚期并发症。普通医生和治疗师对长期放射治疗引起的并发症不够了解。文章介绍了骨系统、肺部、心肌、胃肠道、泌尿生殖系统、造血系统放射损伤以及慢性疼痛综合征的发病机制、临床表现、诊断和治疗。放射治疗晚期并发症的症状是非特异性的,与躯体疾病的症状相似。了解辐射诱发的长期并发症的临床表现有助于及时诊断和治疗。
{"title":"Long-term effects of radiation therapy in outpatient practice","authors":"N. D. Karseladze, O. A. Tiganova, L. Ilyenko, N. Orlova, S. Z. Danelyan","doi":"10.33667/2078-5631-2024-13-34-41","DOIUrl":"https://doi.org/10.33667/2078-5631-2024-13-34-41","url":null,"abstract":"Moscow multidisciplinary clinical center «Kommunarka», Moscow, Russia SUMMARY Radiation therapy is one of the main methods of treating malignant neoplasms. Along with high efficiency, radiation therapy leads to complications in the early and late period. General practitioners and therapists are insufficiently familiar with long-term radiation-induced complications. The article presents data on the pathogenesis, clinical manifestations, diagnosis and treatment of radiation lesions of the bone system, lungs, myocardium, gastrointestinal tract, genitourinary system, hematopoiesis system, as well as chronic pain syndrome. The symptoms of late complications of radiation therapy are nonspecific and similar to the symptoms of somatic diseases. Knowledge of the clinical manifestations of radiation-induced complications in the long term allows timely diagnosis and treatment.","PeriodicalId":18337,"journal":{"name":"Medical alphabet","volume":"24 9","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140982738","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Medical alphabet
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1